Vaccination of cattle against bovine viral diarrhoea

J.T. van Oirschot; C.J.M. Bruschke; P.A. van Rijn

doi:10.1016/S0378-1135(98)00268-5

Vaccination of cattle against bovine viral diarrhoea

J.T. van Oirschot, C.J.M. Bruschke, P.A. van Rijn

Virology & Molecular Biology

Research output: Contribution to journal › Article › Academic › peer-review

114 Citations (Scopus)

Abstract

This brief review describes types and quality (efficacy and safety) of bovine viral diarrhoea virus (BVDV) vaccines that are in the market or under development. Both conventional live and killed vaccines are available. The primary aim of vaccination is to prevent congenital infection, but the few vaccines tested are not highly efficacious in this respect, as shown in vaccination-challenge experiments. Vaccination to prevent severe postnatal infections may be indicated when virulent BVDV strains are prevalent. Live BVDV vaccines have given rise to safety problems. A complication for the development of BVDV vaccines is the wide antigenic diversity among wild-type BVDV. There is ample room for improvement of both the efficacy and safety of BVDV vaccines, and it may be expected that better vaccines, among which marker vaccines, will be launched in the future.

Original language	English
Pages (from-to)	169-183
Journal	Veterinary Microbiology
Volume	64
Issue number	2-3
DOIs	https://doi.org/10.1016/S0378-1135(98)00268-5
Publication status	Published - 1999

Keywords

Antigenic diversity
Bovine virus diarrhoea
Congenital infection
Vaccine efficacy
Vaccine safety

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0378-1135(98)00268-5

Cite this

@article{968851e4b20a484c88b231763bd64462,

title = "Vaccination of cattle against bovine viral diarrhoea",

abstract = "This brief review describes types and quality (efficacy and safety) of bovine viral diarrhoea virus (BVDV) vaccines that are in the market or under development. Both conventional live and killed vaccines are available. The primary aim of vaccination is to prevent congenital infection, but the few vaccines tested are not highly efficacious in this respect, as shown in vaccination-challenge experiments. Vaccination to prevent severe postnatal infections may be indicated when virulent BVDV strains are prevalent. Live BVDV vaccines have given rise to safety problems. A complication for the development of BVDV vaccines is the wide antigenic diversity among wild-type BVDV. There is ample room for improvement of both the efficacy and safety of BVDV vaccines, and it may be expected that better vaccines, among which marker vaccines, will be launched in the future.",

keywords = "Antigenic diversity, Bovine virus diarrhoea, Congenital infection, Vaccine efficacy, Vaccine safety",

author = "{van Oirschot}, J.T. and C.J.M. Bruschke and {van Rijn}, P.A.",

year = "1999",

doi = "10.1016/S0378-1135(98)00268-5",

language = "English",

volume = "64",

pages = "169--183",

journal = "Veterinary Microbiology",

issn = "0378-1135",

publisher = "Elsevier",

number = "2-3",

}

TY - JOUR

T1 - Vaccination of cattle against bovine viral diarrhoea

AU - van Oirschot, J.T.

AU - Bruschke, C.J.M.

AU - van Rijn, P.A.

PY - 1999

Y1 - 1999

N2 - This brief review describes types and quality (efficacy and safety) of bovine viral diarrhoea virus (BVDV) vaccines that are in the market or under development. Both conventional live and killed vaccines are available. The primary aim of vaccination is to prevent congenital infection, but the few vaccines tested are not highly efficacious in this respect, as shown in vaccination-challenge experiments. Vaccination to prevent severe postnatal infections may be indicated when virulent BVDV strains are prevalent. Live BVDV vaccines have given rise to safety problems. A complication for the development of BVDV vaccines is the wide antigenic diversity among wild-type BVDV. There is ample room for improvement of both the efficacy and safety of BVDV vaccines, and it may be expected that better vaccines, among which marker vaccines, will be launched in the future.

AB - This brief review describes types and quality (efficacy and safety) of bovine viral diarrhoea virus (BVDV) vaccines that are in the market or under development. Both conventional live and killed vaccines are available. The primary aim of vaccination is to prevent congenital infection, but the few vaccines tested are not highly efficacious in this respect, as shown in vaccination-challenge experiments. Vaccination to prevent severe postnatal infections may be indicated when virulent BVDV strains are prevalent. Live BVDV vaccines have given rise to safety problems. A complication for the development of BVDV vaccines is the wide antigenic diversity among wild-type BVDV. There is ample room for improvement of both the efficacy and safety of BVDV vaccines, and it may be expected that better vaccines, among which marker vaccines, will be launched in the future.

KW - Antigenic diversity

KW - Bovine virus diarrhoea

KW - Congenital infection

KW - Vaccine efficacy

KW - Vaccine safety

U2 - 10.1016/S0378-1135(98)00268-5

DO - 10.1016/S0378-1135(98)00268-5

M3 - Article

SN - 0378-1135

VL - 64

SP - 169

EP - 183

JO - Veterinary Microbiology

JF - Veterinary Microbiology

IS - 2-3

ER -

Vaccination of cattle against bovine viral diarrhoea

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this